Alnylam/Roche’s Zilebesiran Affirms Efficacy, But Commercially Relevant Data Await

 
• By Alaric DeArment
Alnylam announced results from the KARDIA-1 trial of zilebesiran • Source: Shutterstock

More from Clinical Trials

More from R&D